Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-(pyrimidin-4-yl)-2-(pyrrolidin-1-yl)nicotinonitrile compounds as IKKE, TBK1 and/or SIK2 kinases inhibitors

5-(pyrimidin-4-yl)-2-(pyrrolidin-1-yl)nicotinonitrile compounds as IKKE, TBK1 and/or SIK2 kinases inhibitors

US Patent 11058686 · Granted Jul 13, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Factor XIIA inhibitors2025
MAP4K4 inhibitors2025
MAP4K4 inhibitors2023
Compounds and methods for the treatment of ocular disorders2023
Compounds and methods for the treatment of ocular disorders2023
Compounds and methods for the treatment of ocular disorders2022
Compounds and methods for the treatment of ocular disorders2020
Pyrimidine compounds useful in the treatment of diseases mediated by IKKE and/or2016
Pyrimidine compounds useful in the treatment of diseases mediated by IKKE and/or2016
Pyrimidine compounds as inhibitors of protein kinases IKK epsilon and/or TBK-1, 2015
Pyrimidine compounds as inhibitors of protein kinases IKK epsilon and/or TBK-1, 2015
Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and t2014